Kishimoto Tomono, Imamura Hiroshi, Furukawa Hiroshi, Miyazaki Yasuhiro, Ohshiro Ryouta, Fukunaga Mutsumi, Ohzato Hiroki, Nakayama Takahiro, Takemoto Hiroyoshi, Yamamoto Tameyoshi, Fujimi Satoshi, Tatsuta Masayuki
Dept. of Surgery, Sakai Municipal Hospital.
Gan To Kagaku Ryoho. 2007 Nov;34(12):2120-2.
We report a case of a 48-year-old male with advanced gastric cancer. A total gastrectomy was performed for cancer of remnant stomach. S-1 was administered for cytological cancer cells detected by abdominal cavity lavage as the first-line chemotherapy. After 2 cycles of S-1, cervical lymph nodes were enlarged, and the patient underwent paclitaxel monotherapy as the second-line chemotherapy. After 8 cycles, Virchow lymph nodes were enlarged. The regression of Virchow lymph nodes were observed with a S-1 /CPT-11 combination therapy as the third-line chemotherapy and DOC/CPT-11 as the fourth-line chemotherapy. We then used a combination chemotherapy of CPT-11 60 mg/m2 and CDDP 30 mg/m2 at day 1 and 15, every 4 weeks as the fifth-line chemotherapy. A partial response was achieved after 2 cycles, and has been continued for 7 months. The hematological toxicities and the non-hematological toxicities of grade 2 or higher were not observed. This regimen may be effective for patients with advanced gastric cancer resistant to prior chemotherapy with several agents.